| 000 | 03485nam a2200325 i 4500 | ||
|---|---|---|---|
| 999 |
_c402358 _d402358 |
||
| 001 | 402358 | ||
| 003 | ES-MaUEC | ||
| 005 | 20240618135537.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 230825s2023 sz | fo |||| 0|eng d | ||
| 020 | _a9783031350986 | ||
| 024 | 7 |
_a10.1007/978-3-031-35098-6 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC365 _b2023 EB |
|
| 245 | 0 | 0 |
_aMolecular Imaging of Neurodegenerative Disorders _cedited by Donna J. Cross, Karina Mosci, Satoshi Minoshima |
| 250 | _a1st ed. 2023 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2023 |
|
| 300 | _a1 recurso en línea | ||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 505 | 0 | _a1. What is neurodegeneration? -- 2. Appropriate Use of Biomarkers in Suspected Neurodegenerative Diseases -- 3. Overview of clinically available radiotracers for imaging in neurodegenerative disorders -- 4. FDG PET Imaging Evaluation of Neurodegenerative Dementias -- 5. Amyloid PET Imaging -- 6. Traits and Trammels of Tau Tracer Imaging -- 7. Dopaminergic nerve terminal imaging across the spectrum of aging, idiopathic rapid eye movement (REM) sleep behavior disorder, parkinsonism and dementia -- 8. Cholinergic Imaging and Dementia -- 9. Neuroinflammation Imaging in Neurodegenerative Diseases -- 10. Synaptic PET imaging in neurodegeneration -- 11. MR Imaging of Neurodegeneration -- 12. PET Quantification and Kinetic Analysis -- 13. Semi-quantitative analysis: software-based imaging interpretation - NEUROSTAT/SPM -- 14. Artificial Intelligence Approaches to the Imaging of Neurodegenerative Diseases -- 15. Molecular Imaging In Pediatric Neurodegenerative Disorders -- 16. Simultaneous PET/MR imaging of dementia -- 17. Case-based Guide for Image Interpretation and Reporting.-. | |
| 520 | _aThis book provides a comprehensive review of the role of molecular imaging in neurodegenerative diseases. A growing field, molecular imaging of neurodegeneration is becoming increasingly relevant with an aging population, and this book serves to provide both an introduction to the concept and background of neurodegeneration and an update on the most recent imaging advances. Throughout, chapters will review current applications of neuroimaging in neurodegenerative disorders, like dementia and movement disorders, and increase knowledge of quantification and semi-quantification methods for neuroimaging. Imaging methods such as PET/CT and PET/MR are covered, as well as more advanced technologies like artificial intelligence algorithms and novel radiotracers. Chapters are also intended to improve competency in reporting and interpretation skills with structured information on current practice. The book concludes with a collection of up to date practice cases for the interpretation of neurodegeneration in nuclear medicine imaging. This is an ideal guide for nuclear medicine physicians, neuroradiologists, neurologists, residents, trainees, and related medical professionals caring for patients with neurodegeneration. | ||
| 988 | _aSpringer_Medicine_2023 | ||
| 650 | 7 |
_2embne _9313064 _aSistema nervioso _xDegeneración |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-35098-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b06/2024 _dz _eb _zSI |
||